Ignite Creation Date:
2025-12-24 @ 10:21 PM
Ignite Modification Date:
2026-01-02 @ 5:31 PM
Study NCT ID:
NCT06839235
Status:
RECRUITING
Last Update Posted:
2025-12-24
First Post:
2025-02-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)
Sponsor:
Arbor Biotechnologies
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ABO-101-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None